Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Cigna Corp.

Start price
Target price
Perf. (%)
€299.10
05.02.24
€344.32
05.02.25
5.63%
09:38

Mizuho 
05.02.24 50%
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€117.60
05.02.24
€125.66
05.02.25
-13.42%
15:55

Cantor Fitzgerald 
05.02.24 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€868.50
05.02.24
€1,034.6
05.02.25
5.45%
15:49

Royal Bank of Canada 
05.02.24 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€858.00
05.02.24
€1,006.8
05.02.25
6.74%
15:49

BMO Capital Markets 
05.02.24 50%
buy
AbbVie Inc.

Start price
Target price
Perf. (%)
€156.90
05.02.24
€181.45
05.02.25
13.92%
15:49

BMO Capital Markets 
05.02.24 50%
buy
Teva Pharmaceutical Industries Ltd ADR

Start price
Target price
Perf. (%)
€11.45
05.02.24
€15.82
05.02.25
37.99%
15:50

Barclays PLC 
05.02.24 50%
sell
Karyopharm Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.27
05.02.24
-
05.02.25
-41.77%
17.08.24

Risky Investment
Lokrim 
05.02.24 20%
sell
Atara Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€1.16
05.02.24
-
05.02.25
-68.30%
17.08.24

Probably not worthwhile Investment
Lokrim 
05.02.24 20%
buy
MEI Pharma Inc.

Start price
Target price
Perf. (%)
€4.38
05.02.24
-
05.02.25
-
22.07.23

StockNews.com 
05.02.24 50%
buy
Cigna Corp.

Start price
Target price
Perf. (%)
€306.30
05.02.24
€329.61
05.02.25
3.15%
09:38

Royal Bank of Canada 
05.02.24 50%
buy
Cigna Corp.

Start price
Target price
Perf. (%)
€306.30
05.02.24
€346.37
05.02.25
3.15%
09:38

Cantor Fitzgerald 
05.02.24 50%
buy
AbbVie Inc.

Start price
Target price
Perf. (%)
€157.40
05.02.24
€175.98
05.02.25
13.56%
15:49

Raymond James 
05.02.24 50%
buy
United Therapeutics

Start price
Target price
Perf. (%)
€198.35
05.02.24
€307.26
05.02.25
63.45%
15:49

SVB Leerink LLC 
05.02.24 50%
buy
Becton, Dickinson & Co.

Start price
Target price
Perf. (%)
€220.50
05.02.24
€283.99
05.02.25
-0.13%
15:49

Barclays PLC 
05.02.24 50%
buy
AbbVie Inc.

Start price
Target price
Perf. (%)
€157.40
05.02.24
€172.25
05.02.25
13.56%
15:49

Barclays PLC 
05.02.24 50%
buy
Addus Homecare Corp.

Start price
Target price
Perf. (%)
€81.50
05.02.24
-
05.02.25
38.65%
04.10.24

William Blair 
05.02.24 50%
sell
Coherus Bioscien.

Start price
Target price
Perf. (%)
€1.88
05.02.24
-
05.02.25
33.90%
17.02.24

Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
kostojunior 
05.02.24 0%
sell
Fibrogen Inc.

Start price
Target price
Perf. (%)
€1.72
05.02.24
-
05.02.25
24.42%
17.02.24

Very low/no dividend yield expected
Risky Investment
EBIT decline/stagnation expected
High valuation
kostojunior 
05.02.24 0%
sell
Atara Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€1.32
05.02.24
-
05.02.25
-43.81%
08.02.24

Good culture
Risky Investment
No uniques
me8 
05.02.24 0%
sell
Anavex Life Sciences Corp

Start price
Target price
Perf. (%)
€5.22
04.02.24
-
04.02.25
3.72%
17.08.24

Risky Investment
Higher risks for its business
High valuation
Lokrim 
04.02.24 20%
sell
BioLine RX Ltd ADR

Start price
Target price
Perf. (%)
€1.13
04.02.24
-
04.02.25
-45.13%
17.08.24

Probably not worthwhile Investment
Lokrim 
04.02.24 20%
buy
Actinium Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€4.84
04.02.24
€7.00
31.10.25
-66.38%
19.08.24

Could be very worthwhile Investment >20% year
BiotechBee 
04.02.24 60%
sell
Advaxis Inc.

Start price
Target price
Perf. (%)
€0.059
04.02.24
-
04.02.25
-
23.09.22

StockNews.com 
04.02.24 50%
buy
Amedisys Inc.

Start price
Target price
Perf. (%)
€86.50
04.02.24
-
04.02.25
-1.16%
04.10.24

StockNews.com 
04.02.24 50%
sell
Bellicum Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.071
04.02.24
-
04.02.25
-9.93%
05.03.24

StockNews.com 
04.02.24 50%